| 1 |
34928144 | Discovery and Characterization of Potent Dual P-Glycoprotein and CYP3A4 Inhibitors: Design, Synthesis, Cryo-EM Analysis, and Biological Evaluations. | 2022 Jan 13 |
3 |
| 2 |
34988655 | Association between gene polymorphism and adverse effects in cancer patients receiving docetaxel treatment: a meta-analysis. | 2022 Feb |
2 |
| 3 |
35533911 | An ester derivative of tenacigenin B from Marsdenia tenacissima (Roxb.) Wight et Arn reversed paclitaxel-induced MDR in vitro and in vivo by inhibiting both P-gp and MRP2. | 2022 Aug 10 |
1 |
| 4 |
33125673 | Association of plasma docetaxel levels with ABCB1 gene polymorphisms and tumour response in locally advanced breast cancer patients of South India on neo-adjuvant chemotherapy. | 2021 Mar |
6 |
| 5 |
33464545 | Effect of Food on the Pharmacokinetics of the Oral Docetaxel Tablet Formulation ModraDoc006 Combined with Ritonavir (ModraDoc006/r) in Patients with Advanced Solid Tumours. | 2021 Mar |
1 |
| 6 |
33499040 | Advances in Nanocarriers for Effective Delivery of Docetaxel in the Treatment of Lung Cancer: An Overview. | 2021 Jan 22 |
2 |
| 7 |
33536797 | Pharmacokinetics and Toxicities of Oral Docetaxel Formulations Co-Administered with Ritonavir in Phase I Trials. | 2021 |
1 |
| 8 |
33649517 | Investigating the influence of relevant pharmacogenetic variants on the pharmacokinetics and pharmacodynamics of orally administered docetaxel combined with ritonavir. | 2021 Jun |
1 |
| 9 |
33658706 | Cystine supplementation rebalances the redox homeostasis of microenvironment in non-small cell lung cancer cells and reverses their resistance to docetaxel. | 2021 Dec |
2 |
| 10 |
33709626 | ModraDoc006, an oral docetaxel formulation in combination with ritonavir (ModraDoc006/r), in metastatic castration-resistant prostate cancer patients: A phase Ib study. | 2021 Aug |
1 |
| 11 |
33799432 | Molecular Profiling of Docetaxel-Resistant Prostate Cancer Cells Identifies Multiple Mechanisms of Therapeutic Resistance. | 2021 Mar 14 |
1 |
| 12 |
34268580 | Differences in P-glycoprotein activity in human and rodent blood-brain barrier assessed by mechanistic modelling. | 2021 Sep |
2 |
| 13 |
34326198 | Activation of the ABCB1 Amplicon in Docetaxel- and Cabazitaxel-Resistant Prostate Cancer Cells. | 2021 Oct |
1 |
| 14 |
34439209 | Circulating Cell-Free DNA as Biomarker of Taxane Resistance in Metastatic Castration-Resistant Prostate Cancer. | 2021 Aug 12 |
2 |
| 15 |
32134535 | Docetaxel-resistant prostate cancer cells become sensitive to gemcitabine due to the upregulation of ABCB1. | 2020 May |
3 |
| 16 |
32581798 | Maslinic Acid Enhances Docetaxel Response in Human Docetaxel-Resistant Triple Negative Breast Carcinoma MDA-MB-231 Cells via Regulating MELK-FoxM1-ABCB1 Signaling Cascade. | 2020 |
2 |
| 17 |
32748110 | ABCB1 and ABCC2 genetic polymorphism as risk factors for neutropenia in esophageal cancer patients treated with docetaxel, cisplatin, and 5-fluorouracil chemotherapy. | 2020 Aug |
1 |
| 18 |
32756886 | Association Between ABCB1 Genetic Variants and Persistent Chemotherapy-Induced Alopecia in Women With Breast Cancer. | 2020 Sep 1 |
1 |
| 19 |
30637776 | Influence of ABCB1 C3435T and C1236T gene polymorphisms on tumour response to docetaxel-based neo-adjuvant chemotherapy in locally advanced breast cancer patients of South India. | 2019 Apr |
2 |
| 20 |
30638237 | Formulating a single thioether-bridged oleate prodrug into a self-nanoemulsifying drug delivery system to facilitate oral absorption of docetaxel. | 2019 Feb 26 |
5 |
| 21 |
30814489 | Over-expression of FSIP1 promotes breast cancer progression and confers resistance to docetaxel via MRP1 stabilization. | 2019 Feb 27 |
1 |
| 22 |
31090467 | Co-encapsulation of docetaxel and cyclosporin A into SNEDDS to promote oral cancer chemotherapy. | 2019 Dec |
4 |
| 23 |
31350703 | Involvement of the MDR1 gene and glycolipids in anticancer drug-resistance of human ovarian carcinoma-derived cells. | 2019 Oct |
2 |
| 24 |
31638462 | The ABCB1 3435C > T polymorphism influences docetaxel transportation in ovarian cancer. | 2019 Oct |
1 |
| 25 |
29132176 | Verapamil (VER) Enhances the Cytotoxic Effects of Docetaxel and Vinblastine Combined Therapy Against Non-Small Cell Lung Cancer Cell Lines. | 2018 Mar |
1 |
| 26 |
29679509 | Pharmacokinetic properties of wogonin and its herb-drug interactions with docetaxel in rats with mammary tumors. | 2018 Apr 21 |
2 |
| 27 |
29885788 | Association of Allelic Interaction of Single Nucleotide Polymorphisms of Influx and Efflux Transporters Genes With Nonhematologic Adverse Events of Docetaxel in Breast Cancer Patients. | 2018 Oct |
1 |
| 28 |
30148955 | Co-delivery of Docetaxel and Disulfonate Tetraphenyl Chlorin in One Nanoparticle Produces Strong Synergism between Chemo- and Photodynamic Therapy in Drug-Sensitive and -Resistant Cancer Cells. | 2018 Oct 1 |
1 |
| 29 |
30453546 | Androgen Receptor Splice Variant 7 Drives the Growth of Castration Resistant Prostate Cancer without Being Involved in the Efficacy of Taxane Chemotherapy. | 2018 Nov 16 |
4 |
| 30 |
30555232 | Activation of polymeric nanoparticle intracellular targeting overcomes chemodrug resistance in human primary patient breast cancer cells. | 2018 |
2 |
| 31 |
30555629 | The estrogen receptor variants β2 and β5 induce stem cell characteristics and chemotherapy resistance in prostate cancer through activation of hypoxic signaling. | 2018 Nov 20 |
1 |
| 32 |
28104912 | Paclitaxel-resistant cancer cell-derived secretomes elicit ABCB1-associated docetaxel cross-resistance and escape from apoptosis through FOXO3a-driven glycolytic regulation. | 2017 Jan 20 |
2 |
| 33 |
28698198 | ABCB1 Mediates Cabazitaxel-Docetaxel Cross-Resistance in Advanced Prostate Cancer. | 2017 Oct |
2 |
| 34 |
28787019 | Sensitivity of docetaxel-resistant MCF-7 breast cancer cells to microtubule-destabilizing agents including vinca alkaloids and colchicine-site binding agents. | 2017 |
2 |
| 35 |
28938627 | Prostate Tumor Overexpressed-1 (PTOV1) promotes docetaxel-resistance and survival of castration resistant prostate cancer cells. | 2017 Aug 29 |
1 |
| 36 |
28959367 | Elacridar, a third-generation ABCB1 inhibitor, overcomes resistance to docetaxel in non-small cell lung cancer. | 2017 Oct |
9 |
| 37 |
29714413 | [Expression of AXL enhances docetaxel-resistance of prostate cancer cells]. | 2017 Apr |
1 |
| 38 |
26548759 | Targeting ABCB1 and ABCC1 with their Specific Inhibitor CBT-1® can Overcome Drug Resistance in Osteosarcoma. | 2016 |
1 |
| 39 |
26764117 | Evaluation of TPGS-modified thermo-sensitive Pluronic PF127 hydrogel as a potential carrier to reverse the resistance of P-gp-overexpressing SMMC-7721 cell lines. | 2016 Apr 1 |
2 |
| 40 |
26882453 | Efficacy of tamoxifen in combination with docetaxel in patients with advanced non-small-cell lung cancer pretreated with platinum-based chemotherapy. | 2016 Jun |
3 |
| 41 |
27114800 | Co-treatment by docetaxel and vinblastine breaks down P-glycoprotein mediated chemo-resistance. | 2016 Mar |
2 |
| 42 |
27284014 | Multiplicity of acquired cross-resistance in paclitaxel-resistant cancer cells is associated with feedback control of TUBB3 via FOXO3a-mediated ABCB1 regulation. | 2016 Jun 7 |
1 |
| 43 |
27574448 | Polymorphism of CYP3A4 and ABCB1 genes increase the risk of neuropathy in breast cancer patients treated with paclitaxel and docetaxel. | 2016 |
1 |
| 44 |
27629782 | Roles of aldo-keto reductases 1B10 and 1C3 and ATP-binding cassette transporter in docetaxel tolerance. | 2016 Dec |
3 |
| 45 |
27727250 | Notch-1 Confers Chemoresistance in Lung Adenocarcinoma to Taxanes through AP-1/microRNA-451 Mediated Regulation of MDR-1. | 2016 Oct 11 |
2 |
| 46 |
27941276 | ABCB1 Is Upregulated in Acquisition of Taxane Resistance: Lessons from Esophageal Squamous Cell Carcinoma Cell Lines. | 2016 Dec |
1 |
| 47 |
28642838 | Adaptive pathways and emerging strategies overcoming treatment resistance in castration resistant prostate cancer. | 2016 Oct |
1 |
| 48 |
24888374 | EGFR mediates docetaxel resistance in human castration-resistant prostate cancer through the Akt-dependent expression of ABCB1 (MDR1). | 2015 Apr |
3 |
| 49 |
25410489 | ABCB1 polymorphism as prognostic factor in breast cancer patients treated with docetaxel and doxorubicin neoadjuvant chemotherapy. | 2015 Jan |
2 |
| 50 |
25596703 | Acquisition of docetaxel resistance in breast cancer cells reveals upregulation of ABCB1 expression as a key mediator of resistance accompanied by discrete upregulation of other specific genes and pathways. | 2015 Jun |
1 |